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ABSTRACT
Objectives: To analyze the effect of Javanese turmeric extract on eradicating the initial phase of C. albicans biofilm formation.
Methods: A 100 µl of C. albicans suspension 10−4 was cultured on a 96 - well plate, incubated for 1.5 and 3 h at 37° C and then aspirated and washed 
by phosphate buffer saline before exposure to 100 µl of 5%, 10%, 15%, 20% 25%, 30%, and 35% Javanese turmeric extract for 24 h. The positive 
control was 100 µl of nystatin 100,000 IU.
Results: The eradication effect of 35% Javanese turmeric extract at the two stages of initial phase biofilm was comparable with those of nystatin. The 
viability of C. albicans exposed to the extract at an advanced stage of the early phase of biofilm formation tended to be higher than that at the early 
stage, but the difference was not significant.
Conclusion: The in vitro antifungal effect of Javanese turmeric extract against C. albicans could be effective in eradicating yeast in the early phase of 
biofilm formation.
Keywords: Candida albicans biofilm, Javanese turmeric extract, Curcuma xanthorrhiza Roxb, Viability.
INTRODUCTION
Candida albicans is a commensal microorganism, which, in planctonic 
form, is commonly present in a healthy oral cavity without causing any 
inflammation or pathological condition in the surrounding tissues [1]. 
The planctonic form of C. albicans does not adhere to the adjacent tissue 
surface. However, any environmental changes that lead to increased 
growth and development of the yeast could alter its virulence factors. 
The alteration would result in the development of the yeast from a 
commensal microorganism to an opportunistic pathogen [2]. C. albicans 
is known to be responsible for oral candidiasis, which is suffered mainly 
by subjects with weakened immune systems, such as HIV/AIDS patients, 
the elderly, and denture wearers with bad oral hygiene [3]. About 74% 
of fungal infections in the oral cavity are caused by C. albicans [4].
The key virulent characteristic of C. albicans is its ability to develop 
oral biofilm so that it becomes more resistant to antifungal agents [5]. 
C. albicans develops into an oral biofilm in three phases: Early, 
intermediate, and maturation [6]. The early phase of biofilm formation 
is initiated by the adhesion of the yeast to the surface of oral tissues or 
dentures, where it forms colonies, which is followed by the proliferation 
of yeast cells. In the intermediate phase, the yeast cells undergo a 
morphological change from yeast cells to filamentous cells, which 
indicate the changes from a commensal microorganism to a pathogen. 
As filamentous cells, C. albicans might penetrate the epithelial 
tissue and increase its resistance to the function of the host immune 
system [7,8]. The last phase of biofilm formation is maturation, which 
occurs by extracellular matrix accumulation and increased resistance 
to antifungal agents [7]. Compared to its planctonic form, the biofilm 
form of the microorganism has increased stability and resistance to 
threatening environments, such as the limited availability of nutrition 
and the presence of antimicroorganism agents [9].
The adhesion and proliferation stages that occur in the early phase of 
C. albicans biofilm formation are important initiation stages that allow 
the next phases of biofilm formation to occur. The adhesion of yeast 
cells on the surface of host tissues, which is the first stage of biofilm 
formation, occurs in 1–2 h. At 3 h, the yeast starts to proliferate and 
form colonies. At 6–11 h, C. albicans develops a complex structure with 
hyphal formation [7]. The common clinical procedure in the treatment 
of oral candidiasis is to apply a topical antifungal agent such as nystatin. 
The molecular binding between nystatin and the sterol component 
of the C. albicans cell membrane could lead to the instability of the 
membrane, which in turn would result in ion leakage and cell lysis  [10]. 
Nystatin at a dose of 100,000 IU is commonly applied topically in 
treating oral candidiasis and eliminating any Candida species involved 
in denture stomatitis [11]. Indonesian communities have a long 
tradition of using herbs as medicine. However, the development of 
herbal medicine in using an appropriate scientific procedure began only 
in the past decade. One of the nine herbal plants that are intensively 
studied by the Indonesian Ministry of Health is Javanese turmeric 
(Curcuma xanthorrhiza Roxb.) [12]. The root of Javanese turmeric is 
known to have various medicinal effects, which have been reported 
to have anti-inflammation, antioxidant, antimicrobe, and antifungal 
effects [13]. Javanese turmeric root is comprised various components 
that have medicinal effects, including volatile oil, curcumin, starch, 
protein, cellulose fat, and minerals. Chemical analysis has shown that 
the main substances in Javanese turmeric are starch, fibers, volatile 
oil as phelandren, camphor, tumerol, sineol, borneol, xanthorrhizol, 
and curcuminoid as curcumine, and desmetoksicurcumin [14]. Among 
these components, the active substance is xanthorrhizol which is 
contained in the volatile oil. Xanthorrhizol had been known to have 
antimicrobial and antifungal effects [15,16]Xanthorrhizol is a colorless, 
non-aromatic, and non-volatile compound that has been reported to be 
capable of inhibiting the growth of planctonic C. albicans [17]. However, 
previous studies reported that the Javanese turmeric root even in the 
form of an extract or volatile oil had antifungal effects against planctonic 
C. albicans [18].
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The aim of this study was to investigate the effects of Javanese turmeric 
root extract on eradicating the early phase of C. albicans biofilm.
MATERIALS AND METHODS
Determination of C. albicans suspension concentration
The sample used in this study was laboratory strain C. albicans ATCC 
10231, which was obtained from the Oral Biology Laboratory in the 
Faculty of Dentistry at Universitas Indonesia. The yeast was cultured 
in Sabouraud dextrose agar and incubated at 37°C for 48 h. The 
cultured yeast was then diluted in 1 ml Sabouraud dextrose broth and 
homogenized for 20 s to obtain the master suspension of C. albicans. 
A serial dilution of the master suspension of C. albicans was conducted 
to obtain 10−2, 10−4, 10−6, and 10−8 suspensions by adding PBS. Then, 
C. albicans was cultured on Sabouraud dextrose agar (SDA) which was 
made from each concentration of C. albicans suspension in Duplo (37°C 
for 72 h). Based on the observation of colony formation in the 72-h 
C. albicans cultures (the number of colonies that could still be counted 
accurately), it was determined that the suspension used in this study 
was a concentration of 10−4.
Handling of Javanese turmeric extract
Javanese turmeric root extract was processed by the Research Center of 
Tropical Herbal Plants (BALITTRO) in Bogor, Indonesia. The Javanese 
turmeric root was extracted by the maceration technique using 96% 
ethanol. In this study, 500 ml of extract was derived from 6 kg of 
Javanese turmeric root, which then was centrifuged at 1300 rpm for 20 
min so that in the resulting extract the pellets were separated from the 
supernatant. The supernatant, which contained 41.78% xanthorrhizol, 
was then used in this study and diluted in 10% dimethyl sulfoxide 
(DMSO).
A previous test confirmed that 10% DMSO did not significantly influence 
the growth of planctonic C. albicans. To obtain the concentrations of 
Javanese turmeric root extract that would be analyzed in this study, the 
diluted supernatant of the extract was then further diluted by adding 
10% DMSO.
Minimum inhibition concentration (MIC) and minimum fungicidal 
concentration (MFC)
The concentrations of Javanese turmeric extract that were used in 
this study were 0.25%, 0.5%, 1%, 5%, 10%, 15%, 20%, and 25%. The 
positive control was exposed to 100 µl of 10,000 IU of nystatin, and the 
negative control was exposed to SDB. Into each well of 96-well plate, 
100 µl of the 10−4 C. albicans suspension was placed, to which was added 
100 µl of various concentrations of the extract, nystatin, or SDB. As a 
standard of the extract color, a blank group was made by filling each 
well with 100 µl SDB and 100 µl of the same various concentrations of 
the extract or nystatin but without the C. albicans suspension.
The 96-well plate was then homogenized in an orbital shaker and 
incubated in anerobic condition for 48 h. The optical density (OD) was 
read by a microplate reader at a wavelength of 450 nm. The MIC was 
calculated by the following formula:
 −
 







 In this study, the result of more than 90% was considered as the MIC. To 
determine the MFC, the samples that had been exposed to the Javanese 
turmeric extract started in the MIC concentration were inoculated on 
an SDA medium and incubated at 37°C for 72 h. The experiment was 
conducted in Duplo. The lowest concentration of Javanese turmeric 
extract on which Candida culture showed no colony formation was 
considered as the MFC.
C. albicans biofilm formation and exposure of Javanese turmeric 
root extract
In this experiment, two concentrations of Javanese turmeric extract 
below the MIC up to two concentrations above the MFC were used: 
1%, 5%, 10%, 15%, 20%, 25%, 30%, and 35%. The C. albicans biofilm 
was grown by dripping 100 µl of the 10−4C. albicans suspension on 
to the surface of a 96-well plate, which was then incubated at 37°C 
in an aerobic environment for 1.5 and 3 h. Before exposure to the 
extract, the wells were aspirated and washed by PBS 3 times to 
free the wells from the planctonic C. albicans. Each experimental 
well was exposed to 100 µl of various concentrations of Javanese 
turmeric extract. The positive control wells were exposed to 100 µl 
of 10,000 IU nystatin, and the negative control wells were exposed 
to 100 µl SDB and incubated at 37°C for 24 h. The experiment was 
conducted in Duplo.
Viability test analysis of C. albicans biofilm
The viability of C. albicans in the early phase of the biofilm formation 
was assessed by the methylthiazol tetrazolium (MTT) assay. Into each 
well of C. albicans biofilm, 10 µl of 5 mg/ml MTT solution was added 
and then incubated for 2 h at 37°C in an aerobic condition. Then, 100 µl 
of acidified isopropanol was added into each well, and the 96-well plate 
was placed in an orbital shaker for 1 h. The OD was read by microplate 
reader at a wavelength of 490 nm.
Data Analysis
The data collected about the viability of C. albicans biofilm were 
analyzed using a two-way ANOVA followed by a post hoc Tukey test. 
The correlations between the variables were tested using Pearson’s 
correlation coefficient.
RESULTS
The results of determining the MIC of the Javanese turmeric extract are 
shown in Table 1.
The minimum concentration that inhibited the growth of C. albicans 
equal to or more than 90% was determined as the MIC.
Therefore, as shown in Table 1, the MIC of the Javanese turmeric extract 
against plantonic C. albicans was 10%. The MFC was determined based 
on the minimum concentration that resulted in no colony formation of 
C. albicans cultured on the SDA medium.
As shown in Table 2, the MFC of the Javanese turmeric extract against 
plantonic C. albicans was 25%.
The results of the MTT assay regarding the OD of C. albicans biofilm 
both with and without various concentrations of Javanese turmeric 
extract exposure were then converted into the percentage of viability. 
The results showed trends of the decreased viability of C. albicans 
Table 1: The MIC of Javanese turmeric extract against planctonic 
C. albicans




1 0.25 74.09 94.41 84.25
2 0.5 90.38 68.93 79.66
3 1 89.57 82.35 85.96
4 5 90.74 61.88 76.31
5 10 95.90 92.22 94.06
6 15 81.88 73.11 77.49
7 20 100 68.77 84.39
8 25 100 100 100
9 Positive control 100 100 100
10 Negative control 0 0 0
MIC: Minimum inhibition concentration, C. albicans: Candida albicans
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biofilm along with the increased concentration of the Javanese turmeric 
extract. It could be seen on Table 3 that at 1.5 h, which is considered 
as the adhesion stage in the early phase of the formation of C. albicans 
biofilm, the viability of the fungi decreased significantly compared to the 
negative control even in those exposed to 1% Javanese turmeric extract.
However, the 69,013% C. albicans viability in those exposed to 1% 
extract was also significantly different from those in the positive control 
at 13,5204%. This trend continued in C. albicans culture groups exposed 
to higher concentrations of Javanese extract up to 25%.
A nonsignificant difference of C. albicans viability was shown 
between those exposed to 35% extract (17,728%) and the positive 
control (13,5204%) with p0.237>0.05. The result of the Pearson 
correlation analysis showed −0.959, indicating an inverse strong 
correlation between C. albicans viability and Javanese turmeric extract 
concentration. The higher the extract concentration was the lower the 
viability of the C. albicans biofilm.
Table 4 shows that at 3 h, which is considered the beginning of the 
proliferation stage of C. albicans yeast cells, a trend similar to the 
results shown in Table 1 was observed. All C. albicans biofilm exposed 
to 1–30% Javanese turmeric extract had significantly different viability 
compared to both the negative and positive controls.
However, in the exposure to 35% extract, the viability of C. albicans 
biofilm did not differ from the viability of the positive control. Similar 
to the results of the analysis of C. albicans biofilm at 1.5 h, the results 
of Pearson’s correlation analysis of the data C. albicans biofilm at 3 h 
was −0.981, which showed an inverse strong correlation between 
C. albicans viability and the concentration of the Javanese turmeric 
extract. The higher the extract concentration was the lower the viability 
of the C. albicans biofilm.
DISCUSSION
In this study, SDA and SDB were chosen as the medium for growing 
C. albicans because they are the standard medium of fungi, and they 
contain peptone and dextrose, which support the growth of yeast. In 
addition, the medium has a low pH, which is suitable for growing fungi 
and preventing bacterial contamination [18].
The MIC and MFC of Javanese turmeric extract against platonic C. albicans 
shown by this study were 10% and 25%, respectively. These results 
aligned with previous studies that examined the efficacy of Javanese 
turmeric extract against C. albicans. xanthorrhizol, which is the active 
component in the volatile oil found in Javanese turmeric extract, was 
reported to have an MIC of 2.5–15 mg/L and an MFC of 2.5–15 mg/L [17].
In this study, the results of the MTT assay showed that Javanese turmeric 
extract had a significant effect on reducing the viability of C. albicans in 
the early stages of biofilm formation. The results of the ANOVA analysis 
confirmed that even in a 1% concentration, the Javanese turmeric 
extract exposed to C. albicans biofilm at both 1.5 and 3 h reduced the 
viability of the yeast to a significantly lower percentage compared to 
the negative control. However, although at concentrations of 1–30%, 
exposure to the Javanese turmeric extract led to the decreased viability 
of C. albicans biofilm, nonetheless, it was still significantly different 
from the viability of the positive control, which was exposed to nystatin. 
A similar efficacy of Javanese turmeric extract to nystatin in reducing 
the viability of C. albicans biofilm could be seen in 35% concentration.
The results of this study also showed the same pattern in the adhesion 
and proliferation stages of the early phase of C. albicans biofilm, that 
Table 2: The MFC of Javanese turmeric extract against plantonic 
C. albicans




1 5 79 497 288
2 10 25 105 65
3 15 31 282 156.5
4 20 0 31 15.5
5 25 0 0 0
6 Positive control 0 0 0
7 Negative control ∞ ∞ ∞
MFC: Minimum fungicidal concentration, C. albicans: Candida albicans
Table 3: The viability of C. albicans at 1.5 h in biofilm exposed to various concentrations of Javanese turmeric extract
Extract concentration (%) Mean of viability(% ± SD) p value to positive control p value to negative control
1 69.9131±2.01452 0.000 0.000
5 74.2896±2.13688 0.000 0.000
10 56.982±1.78775 0.000 0.000
15 53.7146±0.78927 0.000 0.000
20 52.8825±1.40054 0.000 0.000
25 37.056±0.60285 0.000 0.000
30 20.1203±2.42488 0.002 0.000
35 17.728±2.99728 0.237 0.000
Positive control 13.5204±2.59803 - 0.000
Negative control 100±0 0.000 -
C. albicans: Candida albicans, SD: Standard deviation
Table 4: Viability of C. albicans biofilm at 3 h of exposure to various concentrations of Javanese turmeric extract
Extract concentration (%) Mean of viability (%±SD) p value to positive control p value to negative control
1 77.4401±0.49371 0.000 0.000
5 73.8000±1.62356 0.000 0.000
10 59.5841±2.01595 0.000 0.000
15 56.0247±1.18029 0.000 0.000
20 39.3691±1.72952 0.000 0.000
25 41.2655±0.48739 0.000 0.000
30 20.1693±2.87002 0.002 0.000
35 17.0322±0.72569 0.342 0.000
Kontrol positif 14.0497±1.27843 - 0.000
Kontrol negatif 100±0 0.000 -
C. albicans: Candida albicans, SD: Standard deviation
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is, the higher the concentration of the extract, the lower the viability 
of C. albicans in the biofilm. The dose-dependent effect of Javanese 
turmeric extract in reducing the viability of C. albicans biofilm might 
be due to the higher concentration of xanthorrhizol in the higher 
concentration of the extract, which then led to a stronger, destructive 
effect on the cell membranes of the fungi. Because xanthorrhizol 
contains (-OH), it penetrated the biofilm and bound to the C. albicans 
cell membrane, which caused cell degradation [12]. In this study, the 
comparison of MIC and MFC with the eradication effect of the extract 
showed that against the planctonic C. albicans, the extract inhibited 
the growth of C. albicans at 10%, and it was able to stop the fungi 
growth at 25%. However, against C. albicans in the early phase of 
biofilm formation, at a concentration of 35%, the extract was capable of 
reducing 90% of the yeast’s viability, but it was not able to eradicate it 
completely. A higher concentration of the extract was required to inhibit 
the growth of ‑icans in its early phase of biofilm formation than in the 
planctonic form. This result might have been due to the limited activity 
of the xanthorrhizol contained in the extract, which could only erode 
the superficial part of the biofilm. Therefore, the affected C. albicans, 
which then underwent cell lysis, colonized only the superficial part of 
the biofilm. The lysis yeast cells on the superficial part of the biofilm 
then degraded from the biofilm and reduced the percentage of the 
viability of the living cells in the biofilm [19]. The adhesion stage is 
important in initiating the formation of biofilm and inducing the growth 
of the yeast by proliferating [6]. The ability of the yeast to adhere to the 
host tissues and denture surface was supported by the activity of the 
adhesion protein in the C. albicans cell membrane [1,8].
The results of this study showed that the eradication effect of Javanese 
turmeric extract against C. albicans in the adhesion phase and the 
proliferation phase was both at a concentration of 35%. This result 
indicates that the resistance of the yeast from the adhesion stage (at 
1–2 h) to the proliferation stage (at 3–6 h) in the early phase of biofilm 
formation remained the same. The proliferation of C. albicans cells did 
not affect their resistance to the surrounding environment. Another 
possibility is that at 3 h, the yeast had just begun the proliferation stage, 
which continued to 11 h [20]. Thus, at 3 h, there were no significant 
changes from the condition at 1, 5 h in the condition of the biofilm.
CONCLUSION
Javanese turmeric extract has an inhibiting effect against C. albicans both in 
planctonic form and in the early phase of biofilm formation. The antifungal 
effect of Javanese turmeric extract against platonic C. albicans is stronger 
than its eradication effect against C. albicans biofilm. At a concentration of 
35%, Javanese turmeric extract reduced 90% of the viability of C. albicans 
in the adhesion and proliferation stages of the early phase of biofilm 
formation. No differences were found in the eradication effects of Javanese 
turmeric extract between the adhesion and proliferation stages of the 
early phase the formation of C. albicans biofilm.
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